TRIMM-2: Favourable results of talquetamab plus daratumumab for MM Presented ByDr Ajai Chari, Mount Sinai School of Medicine, NY, USA TrialPhase 1, TRIMM-2 ConferenceASH 2021 4 February, 2022 11:16
ASH 2021 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceASH 2021 4 January, 2022 08:00